Shengtai Pharmaceutical, Inc. to Present at Two Conferences
May 19 2008 - 7:00AM
PR Newswire (US)
WEIFANG, Shandong Province, China, May 19
/Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc.
(OTC:SGTI) (BULLETIN BOARD: SGTI) ('Shengtai Pharmaceutical' or
'the Company'), a leading manufacturer and distributor of
high-quality, pharmaceutical grade glucose products in China, today
announced that the Company's management will present at two
upcoming investor conferences, including the Brean Murray, Carret
& Co. All-Cap All-China Conference in New York City and the
Roth China Discovery Tour in China. Brean Murray, Carret & Co.
All-Cap, All-China Conference Date: Monday, May 19, 2008 Time: 1:15
p.m. EST Time Venue: Jade Room, the Waldorf Astoria, New York City
This conference will feature formal presentations and one-on-one
meetings with over 100 Chinese companies. Interested parties and
investors may find more information by contacting the BMC
Conference Coordinator, Barbara Bradley at (212) 702-6616 or . Roth
China Discovery Tour Date: Tuesday, May 20, 2008 Time: 8:00 a.m.
China Time Venue: Hotel Regent, Beijing, China The Roth China
Discovery Tour will bring together executives from more than 60
companies in 7 cities throughout China. The event will combine
factory visits with management presentations in a mini-conference
format. Interested parties and institutional investors may find
more information by e-mailing and referencing ROTH China Discovery
Tour 2008. About Shengtai Pharmaceutical, Inc. Shengtai
Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai
Holding, Inc. (SHI), a New Jersey corporation, and the Chinese
operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is
a leading manufacturer and supplier of glucose products, which
include pharmaceutical grade glucose used for medical purposes, and
glucose and cornstarch products for the food and beverage industry
and for industrial production in China. For more information about
Shengtai Pharmaceutical, Inc. please visit
http://www.shengtaipharmaceutical.com/ . For more information,
please contact: Company Contact: Ms. Melody Shi CFO Shengtai
Pharmaceutical, Inc. Tel: +1-949-468-7078 Email: Investor Relations
Contact: Mr. Crocker Coulson President CCG Elite Investor Relations
Tel: +1-646-213-1915 (NY Office) Email: Web:
http://www.ccgelite.com/ DATASOURCE: Shengtai Pharmaceutical, Inc.
CONTACT: Ms. Melody Shi, CFO of Shengtai Pharmaceutical, Inc.,
+1-949- 468-7078, or ; or Mr. Crocker Coulson, President of CCG
Elite Investor Relations, +1-646-213-1915 (NY Office), or , for
SGTI Web Site: http://www.ccgelite.com/
http://www.shengtaipharmaceutical.com/
Copyright